PLA2G7 antibody
Quick Overview for PLA2G7 antibody (ABIN7176818)
Target
See all PLA2G7 (Lp-PLA2) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Cross-Reactivity
- Human, Mouse
-
Purification
- Protein G purified
-
Immunogen
- Recombinant LP-PLA2 Protein
-
Isotype
- IgG1, IgG1 kappa
-
-
-
-
Application Notes
- Recommended dilution:WB:1:500-1:5000,IHC:1:50-1:500,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- PLA2G7 (Lp-PLA2) (Lipoprotein-Associated phospholipase A2 (Lp-PLA2))
-
Alternative Name
- PLA2G7
-
Background
-
Background: Platelet-activating factor acetylhydrolase deficiency (PAFAD) : An enzymatic deficiency that results in exacerbated bodily response to inflammatory agents. It can be associated with several disease states including inflammatory gastrointestinal disorders, asthma and atopy. Asthmatic individuals with PAFAD may manifest aggravated respiratory symptoms.
Aliases: PLA2G7, PAFAH, LP-PLA2
-
UniProt
- Q13093
-
Pathways
- Peptide Hormone Metabolism
Target
-